Abstract：
Currently, the significance of the chronic prostatitis (CP) is undoubted. Oxidative stress is considered as one of the standard mechanisms of cellular damage that is associated with inflammatory diseases such as CP. When choosing the combination therapy for this group of patients, a correction of oxidative stress is pathogenetically justified. Literature data about the pathogenetic feasibility and prospects of using a biologically active complex containing flavonoids and carotenoids quercetin, lycopene and naringin as part of the combination treatment of patients with CP are presented in the article. Considering the various effects of the biologically active complex Querceprost, containing quercetin, lycopene and naringin, among which antioxidant, anti-inflammatory, antimicrobial and immunomodulatory are of greatest importance, as well as taking into account the synergistic effect of flavonoids and carotenoids, we suggest that Querceprost is promising component of combination treatment of patients with CP.
摘要：
目前,慢性前列腺炎（CP）的意义是毋庸置疑的。氧化应激被认为是与诸如CP的炎性疾病相关的细胞损伤的标准机制之一。在为这组患者选择联合治疗时，纠正氧化应激在发病机制上是合理的。有关使用含有类黄酮和类胡萝卜素槲皮素的生物活性复合物的致病可行性和前景的文献数据，本文介绍了番茄红素和柚皮苷作为CP患者联合治疗的一部分。考虑到生物活性复合物Querceprost的各种作用，含有槲皮素,番茄红素和柚皮苷,其中抗氧化剂，抗炎,抗菌和免疫调节是最重要的，以及考虑到类黄酮和类胡萝卜素的协同作用，我们认为,Querceprost是CP患者联合治疗的有前景的组成部分.
